These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Programmed Death Ligand 1 Testing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and Staging of Non-Small Cell Lung Cancer. Smith A, Wang H, Zerbo A, Beaudoin S, Ofiara L, Fiset PO, Benedetti A, Gonzalez AV. J Bronchology Interv Pulmonol; 2020 Jan; 27(1):50-57. PubMed ID: 31513030 [Abstract] [Full Text] [Related]
8. Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples. Chauhan A, Siegel L, Freese R, Racila E, Stewart J, Amin K. Diagn Cytopathol; 2021 Mar; 49(3):355-362. PubMed ID: 33142053 [Abstract] [Full Text] [Related]
9. Comparing the Clinical Performance of the New 19-G ViziShot FLEX and 21- or 22-G ViziShot 2 Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Needles. Minami D, Ozeki T, Okawa S, Takada K, Iwamoto Y, Kayatani H, Sato K, Fujiwara K, Shibayama T. Intern Med; 2018 Dec 15; 57(24):3515-3520. PubMed ID: 30146572 [Abstract] [Full Text] [Related]
18. EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer. Sakakibara R, Inamura K, Tambo Y, Ninomiya H, Kitazono S, Yanagitani N, Horiike A, Ohyanagi F, Matsuura Y, Nakao M, Mun M, Okumura S, Inase N, Nishio M, Motoi N, Ishikawa Y. Clin Lung Cancer; 2017 Sep 15; 18(5):527-534.e1. PubMed ID: 28111119 [Abstract] [Full Text] [Related]
20. Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterations. Mei P, Shilo K, Wei L, Shen R, Tonkovich D, Li Z. Cancer Cytopathol; 2019 Jul 15; 127(7):447-457. PubMed ID: 31025831 [Abstract] [Full Text] [Related] Page: [Next] [New Search]